CFLED(SZ:300301)2025-04-27 07:40Revenue and Profit - Revenue for Q1 2025 was ¥117,875,840, a decrease of 13.94% compared to ¥136,962,605 in the same period last year[4] - Net profit attributable to shareholders was -¥23,955,869.54, representing a decline of 631.43% from -¥3,275,223.30 year-on-year[4] - Net profit for the period was a loss of ¥23,962,499.98, compared to a loss of ¥3,257,055.80 in the previous period, indicating a significant increase in losses[20] - Basic and diluted earnings per share were both reported at -0.0289, compared to -0.0041 in the previous period[20] Cash Flow - Net cash flow from operating activities was -¥25,444,393.53, down 76.28% from -¥14,434,002.62 in the previous year[10] - The net cash flow from investing activities was -¥2,973,787.91, a decline of 123.44% compared to ¥12,685,402.47 in the previous year[10] - The net cash flow from financing activities was -¥32,880,739.48, a significant decrease of 529.40% from ¥7,657,349.53 in the same period last year[10] - Operating cash flow net amount was negative at ¥25,444,393.53, worsening from a negative cash flow of ¥14,434,002.62 in the prior period[22] - Net cash flow from financing activities was negative at -32,880,739.48, compared to a positive cash flow of 7,657,349.53 in the previous period[23] - Total cash and cash equivalents at the end of the period decreased to 13,968,810.49 from 74,652,540.80 at the beginning of the period, reflecting a net decrease of 60,683,730.31[23] Assets and Liabilities - Total assets decreased by 9.57% to ¥694,350,366.65 from ¥767,857,649.91 at the end of the previous year[4] - Total assets and equity decreased to ¥694,350,366.65 and ¥13,295,531.79 respectively, down from ¥767,857,649.91 and ¥31,640,657.41[18] - Total liabilities decreased from 736,216,992.50 to 681,054,834.86, a reduction of approximately 7.5%[16] Shareholder Information - The total number of common shareholders at the end of the reporting period is 19,780[11] - The top 10 shareholders hold a total of 7.14% (59,258,158 shares) by Nanchang Xinwang Capital[11] Expenses - Management expenses increased by 39.17% to ¥21,392,470.13, primarily due to higher equity incentive costs[9] - Research and development expenses increased to ¥11,107,007.01 from ¥10,629,073.87, reflecting a growth of approximately 4.5%[19] - Sales expenses rose to ¥8,413,481.63 from ¥7,656,818.12, an increase of about 9.9%[19] - Total operating costs slightly decreased to ¥138,179,081.95 from ¥140,188,013.33, a reduction of about 1.4%[19] Other Income and Receivables - Other income decreased by 57.31% to ¥1,524,676.25, mainly due to a reduction in government subsidies received[9] - Other income decreased to ¥1,524,676.25 from ¥3,571,862.91, a drop of about 57.5%[19] - Accounts receivable increased from 102,956,390.92 to 124,318,683.28, an increase of about 20.7%[15] Company Issues and Future Plans - The company is facing a potential fine of 4 million RMB due to inflated profits and accounts receivable[13] - The company reported a significant decrease in cash flow, indicating potential liquidity issues[15] - The company has not disclosed any new product developments or market expansion strategies in the current report[11] - The company did not undergo an audit for the first quarter report, which was released on April 28, 2025[24] - The company plans to implement new accounting standards starting in 2025, which may affect financial reporting[24]